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ABSTRACT 1 
Skin concentrations of topically administered compounds need to be considered in order 2 
to evaluate their efficacies and toxicities.  This study investigated the relationship 3 
between the skin permeation and concentrations of compounds, and also predicted the 4 
skin concentrations of these compounds using their permeation parameters.  5 
Full-thickness skin or stripped skin from pig ears was set on a vertical-type diffusion 6 
cell, and lidocaine (LID) solution was applied to the stratum corneum (SC) in order to 7 
determine in vitro skin permeability.  Permeation parameters were obtained based on 8 
Fick’s second law of diffusion.  LID concentrations at each depth of the SC were 9 
measured using tape-stripping.  Concentration-depth profiles were obtained from 10 
viable epidermis and dermis (VED) by analyzing horizontal sections.  The 11 
corresponding skin concentration at each depth was calculated based on Fick’s law 12 
using permeation parameters and then compared with the observed value.  The steady 13 
state LID concentrations decreased linearly as the site became deeper in SC or VED.  14 
The calculated concentration-depth profiles of the SC and VED were almost identical to 15 
the observed profiles.  The compound concentration at each depth could be easily 16 
predicted in the skin using diffusion equations and skin permeation data.  Thus, this 17 
3 
 
method was considered to be useful for promoting the efficient preparation of topically 1 
applied drugs and cosmetics. 2 
3 
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1. Introduction 1 
 2 
 The efficacy and toxicity of active compounds have been classified into direct 3 
and indirect reactions.  A direct reaction is caused by a compound directly binding to 4 
the receptor, and the relationship between the reaction and concentration of the 5 
compound can be described by Hill’s equation (Kano et al., 2006).  Although indirect 6 
reactions have been attributed to the promotion or inhibition of enzymatic reactions by 7 
an active compound, the reaction itself is also a function of the concentration of the 8 
compound.  Thus, accurately measuring the concentrations of active molecules at the 9 
site of action enables a high precision prediction for their efficacies and toxicities.   10 
Two main sites of action have been identified for compounds that are absorbed 11 
into the body through the skin.  One is sites apart from the skin while the other is the 12 
skin itself.  In the former case, a compound is absorbed through the skin and then 13 
carried to the site of action by the blood circulation.  The concentrations of active 14 
molecules at the site of action have generally been described as a function of the blood 15 
concentration (Huffman et al., 1976; Sheiner et al., 1977; Vozeh et al., 1985).  16 
Moreover, blood concentration-time curves can be predicted using skin permeation 17 
parameters, such as the flux and permeability coefficient, which are obtained from in 18 
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vitro skin permeation experiments (Sato et al., 1988a; Sato et al., 1988b; Hatanaka et al., 1 
1994; Nakamura et al., 2012).  Skin permeation behaviors and blood concentration 2 
profiles for compounds having sites of action other than the skin need to be elucidated 3 
in more detail. 4 
On the other hand, the importance of the skin concentration is greater than that 5 
of skin permeation behavior for topical drugs, cosmetics, and compounds that are 6 
capable of causing skin irritation and inflammation.  A large number of sites of action 7 
have been identified, from the skin surface for sunscreens and skin protective agents to 8 
the viable epidermis and dermis (VED) for antimicrobials, antipruritics, and functional 9 
cosmetics.  Therefore, the concentration at each skin depth is needed in order to 10 
evaluate the efficacy and safety of topically active compounds.  11 
 The skin concentrations of compounds have been measured using various 12 
methods; suction blister (Kiistala, 1968), punch and shave biopsies (Surber et al., 1993), 13 
heating (Surber et al., 1990), autoradiography (Schaefer et al., 1978), tape-stripping 14 
(Pershing et al., 1992; Rougier et al., 1983; Tojo and Lee, 1989; N'Dri-Stempfer et al., 15 
2009) and Raman spectrophotometry (Lademann et al., 2012).  However, these 16 
evaluation methods are problematic for various reasons such as the difficulties 17 
associated with using human skin, incomplete removal of the applied formulation from 18 
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the skin surface, and low extraction ratio of compounds from the skin.  Furthermore, 1 
measuring skin concentrations at each depth is more difficult than determining mean 2 
concentrations in the whole skin.   3 
We previously demonstrated that the mean concentration in the whole skin 4 
during steady state permeation could be predicted from skin permeation parameters 5 
based on Fick’s second law of diffusion (Sugibayashi et al., 2010).  In the present 6 
study, we attempted to establish an accurate and convenient method for predicting skin 7 
concentration-depth profiles during steady state permeation based on the skin 8 
permeation parameters of topically active compounds. 9 
 10 
2. Materials and methods 11 
 12 
2.1.Materials 13 
 14 
 Lidocaine (LID) hydrochloride monohydrate and mepivacaine hydrochloride 15 
were purchased from Sigma Aldrich (St. Louis, MO, U.S.A.).  4-Hydroxy benzoic acid 16 
and sodium 1-heptanesulfonate were obtained from Tokyo Chemical Industry Co., Ltd. 17 
(Tokyo, Japan).  Ammonium acetate was obtained from Wako Chemical Industries, 18 
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Ltd. (Osaka, Japan).  Other chemicals and reagents were of special grade or HPLC 1 
grade commercially obtained and used without further purification.  The frozen ears of 2 
male and female pigs (LWD, 6-12 month) were obtained from Saitama Experimental 3 
Animals Supply Co., Ltd. (Saitama, Japan).  The skin was stored at -80°C until 4 
permeation experiments.   5 
 6 
2.2.Skin permeation experiments 7 
 Frozen pig ears were thawed at 32°C and full-thickness skin was excised after 8 
being cleaned with pH 7.4 phosphate-buffered saline (PBS).  Stripped skin was 9 
obtained by tape-stripping the stratum corneum (SC) 30 times with adhesive tape prior 10 
to its excision from the pig ear (Klang et al., 2012).  Excess fat was trimmed off from 11 
the excised skin, and the skin sample was set in a vertical-type diffusion cell (effective 12 
diffusion area, 1.77 cm2) in which the receiver chamber was warmed to 32°C.  After a 13 
1-h equilibration period with PBS, pH 5.0, 7.4, or 10 PBS containing 1.0 mg/mL of LID 14 
(volume; 1.0 mL) was applied to the SC side as a donor solution, and pH 7.4 PBS 15 
(volume; 6.0 mL) was added to the VED side as a receiver solution.  The receiver 16 
solution was stirred with a stirrer bar on a magnetic stirrer and maintained at 32°C 17 
throughout the experiments.  An aliquot (500 µL) was withdrawn from the receiver 18 
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chamber and the same volume of PBS was added to the chamber to keep the volume 1 
constant.  The penetrant concentration in the receiver chamber was determined by 2 
HPLC or LC/MS/MS. 3 
 4 
2.3.Measurement of skin pH 5 
 The pH values of the surface (SC for full-thickness skin and viable epidermis 6 
for stripped skin or full-thickness skin after tape-stripping) and dermis sides of the skin 7 
were measured before and after skin permeation experiments by a Skin-pH meter 8 
(Derma Unit SCC3; Courage+Khazaka Co., Cologne, Germany).  9 
 10 
2.4.Determination of skin concentrations 11 
 12 
2.4.1. LID concentration-depth profile of SC 13 
 LID concentrations were measured at various depths of the SC during steady 14 
state permeation according to the method of N'Dri-Stempfer et al. (2009).  The donor 15 
solution for the skin permeation experiment was removed and the SC side was rinsed 16 
three times with 1.0 mL of PBS.  The SC was removed by the sequential application 17 
and removal of adhesive tape (Cellotape® CT-15, Nichiban, Tokyo, Japan).  Each tape 18 
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was immersed in 1.0 mL of PBS for 1 h to extract LID.  LID in the extraction liquids 1 
was analyzed by HPLC.  The amount of the SC removed was different with each 2 
tape-stripping; therefore, the total thickness of the SC (Lsc) and thickness of the 3 
remaining SC (Lsc-x) was estimated based on the change in transepidermal water loss 4 
(TEWL), i.e. (Kalia et al., 1996), 5 
xL
CDK
TEWL
sc
ww
‐
Δ
=                                              (1) 6 
where Kw is the partition coefficient of water between the SC and epidermis, Dw is the 7 
diffusion coefficient of water in the SC, ΔC is the concentration difference across the 8 
SC and x is the thickness of the SC removed by tape-stripping, which is calculated 9 
from the gain in mass of adhesive tapes assuming 1.0 g/cm3 of SC density . The plot of 10 
reciprocal of TWEL versus x is linear and the slope and intercept yield Lsc value (Lsc = 11 
- intercept / slope). 12 
 13 
2.4.2. LID concentration-depth profile of VED 14 
 After skin permeation reached a steady state, the donor solution was removed 15 
and both the SC and VED sides were washed with PBS.  The SC was removed by 16 
tape-stripping and the remaining VED was frozen using dry ice.  The frozen VED was 17 
vertically cut to an approximately 0.5 cm square using a razor blade, embedded in super 18 
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cryoembedding medium (Leica Microsystems, Tokyo, Japan), and frozen quickly in 1 
isopentane cooled with dry ice.  A cryostat (CM3050S, Leica Microsystems) was used 2 
to prepare horizontal slices of the VED.  Each of the 200-µm thick serial VED slices 3 
was placed into a microtube and LID was extracted by immersing the slices in 1.0 mL 4 
of PBS for 1 h.  LID in the extraction liquids was analyzed by LC/MS/MS. When the 5 
LID concentration in the first and second slices, the rippled layer of viable epidermis 6 
immediately under the SC, was high more than 10 times of that in next slices, it was 7 
considered to be the insufficient SC removal and excluded from the data. 8 
 9 
2.5.Analytical methods for LID 10 
 11 
2.5.1. HPLC 12 
 The withdrawn sample containing LID (200 µL) was mixed with 200 µL 13 
acetonitrile containing an internal standard (4-hydroxy benzoic acid) and centrifuged at 14 
4°C for 5 min.  The obtained supernatant (20 µL) was injected into an HPLC system.  15 
The HPLC system (Shimadzu; Kyoto, Japan) consisted of a system controller 16 
(CBM-20A), pump (LC-20AD), auto-sampler (SIL-20AC), column oven (CTO-20A), 17 
UV detector (SPD-M20A), and analysis software (LC Solution).  The column was 18 
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Inertsil® ODS-3 4.6 mm×150 mm (GL Sciences Inc.; Tokyo, Japan), which was 1 
maintained at 40°C.  The mobile phase was 0.1% phosphoric acid in water : 2 
acetonitrile = 7 : 3 containing 5.0 mM sodium 1-heptanesulfonate, and the flow rate was 3 
adjusted to 1.0 mL/min.  LID was detected at UV 230 nm.   4 
 5 
2.5.2. LC/MS/MS 6 
The withdrawn sample containing LID (200 µL) was mixed with 200 µL 7 
acetonitrile containing an internal standard (mepivacaine) and centrifuged at 4°C for 5 8 
min.  The obtained supernatant (10 µL) was injected into an LC/MS/MS system.  The 9 
LC/MS/MS system consisted of a system controller (CBM-20A; Shimadzu), pump 10 
(LC-20AD; Shimadzu), auto-sampler (SIL-20ACHT; Shimadzu), column oven 11 
(CTO-20A; Shimadzu), detector (4000QTRAP; AB Sciex, Tokyo, Japan), and analysis 12 
software (Analyst® version1.4.2; Shimadzu).  The column was Shodex ODP2 HP-2B 13 
2.0 mm×50 mm (Showadenko Inc.; Tokyo, Japan), which was kept at 40°C.  The 14 
mobile phase was 10 mM ammonium acetate in water : acetonitrile = 7 : 3, and the flow 15 
rate was 0.2 mL/min. 16 
  17 
2.6.Prediction of skin concentrations 18 
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 Fig. 1 shows a schematic diagram of the concentration-depth profiles for 1 
two-layered diffusion models consisting of the SC and VED for skin permeation 2 
(Sugibayashi et al., 2010).  The vertical and horizontal axes indicate the concentration 3 
of the penetrant and depth from the skin surface, respectively.  The hatched area shows 4 
the amount of penetrant in a unit area of the skin, and the product of the diffusion 5 
coefficient and slope of the VED layer was used to determine the permeation rate.  The 6 
concentration of the penetrant at position x in the SC (0 ≤ x ≤ Lsc) under steady state 7 
permeation (Csc,ss) can be represented by 8 
x
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(2) 9 
where Cv is the applied concentration of the penetrant in the vehicle, Ksc is the partition 10 
coefficient from vehicle to the SC, Ptot and Pved are the permeability coefficients through 11 
full-thickness and stripped skin, respectively, and Lsc is the thickness of the SC.  12 
The steady state concentration of the penetrant at position x in the VED (Cved,ss , 13 
Lsc ≤ x ≤ Lsc+Lved) is expressed as 14 
)
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(3) 15 
where Kved is the partition coefficient of the penetrant from vehicle to the VED and Lved 16 
is the thickness of the VED. 17 
Skin permeation parameters, which were required to predict the penetrant 18 
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concentration at each depth of the VED (Pved and Kved), could be obtained by fitting 1 
permeation data through stripped skin to the one-layered diffusion model (Ohmori et al., 2 
2000).  The parameters for SC (Psc and Ksc) were then calculated in the SC by fitting 3 
permeation data through full-thickness skin to the two-layered diffusion model using 4 
fixed values for Pved and Kved. These model adaptations were carried out by the weighted 5 
least-square method using a quasi-Newton algorithm on solver-function of Microsoft 6 
Excel 2007. The steady state concentration (Csc,ss, and  Cved,ss) – skin depth (x) profile 7 
was calculated from equations (2) and (3) using the fixed values of skin permeation 8 
parameters and thicknesses (Lved and Lsc). 9 
 10 
Fig. 1 11 
 12 
3. Results 13 
 14 
3.1.Skin permeation of LID 15 
 16 
3.1.1. Effect of pH on the skin permeation of LID 17 
 Fig. 2 shows the cumulative amount of LID that permeated through 18 
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full-thickness and stripped skin from donor solutions at several pH values. The 1 
permeation of LID through both types of skin was high in the order of pH 10, pH 7.4, 2 
and pH 5.0.  However, differences among pH values were lower for stripped skin than 3 
for full-thickness skin.  The permeation parameters Ptot, Pved, Ksc, and Kved were 4 
calculated by fitting data in Fig. 2 to diffusion models (Ohmori et al., 2000) and are 5 
listed in Table 1.  The parameter values for pH 7.4 were similar to those for pH 10.  6 
When these values were compared with those for pH 5.0, Ptot and Ktot were 52 and 81 7 
times higher, respectively. The similar tendencies were observed in Pved and Kved values, 8 
although the differences between pH 5.0 and the other pHs were smaller than those in 9 
Ptot and Ktot. 10 
 11 
Fig. 2 12 
Table 1 13 
 14 
3.1.2. Changes in skin pH after permeation 15 
 The pH values of the surface (SC for full-thickness skin and viable epidermis 16 
for stripped skin or full-thickness skin after tape-stripping) and dermis sides of the skin 17 
before and after permeation experiments are listed in Table 2.  The pH values of the 18 
16 
 
VED in full-thickness skin before and after the permeation experiments were 1 
approximately 7.4, regardless of the applied donor solutions.  The values for stripped 2 
skin were also approximately 7.4, except for the donor solution at pH 10.  3 
 Subsequent skin concentration-depth profiles under steady state permeation 4 
were predicted at pH 7.4 because of the low skin permeability observed at pH 5.0 and 5 
changes in skin pH at pH 10. 6 
 7 
Table 2 8 
 9 
3.2.Skin concentration of LID under steady state permeation 10 
 11 
3.2.1. LID concentration-SC depth profile 12 
Steady state LID concentrations were measured at various depths in the SC 13 
after skin permeation experiments, in which pH 7.4 donor solution was applied for 8 h, 14 
and plotted with the calculated values in Fig. 3. The calculation was performed using 15 
equation (2) with permeation parameters obtained from the corresponding skin 16 
permeation data in Fig. 2.  Due to differences in the thickness of the SC among skins, 17 
data for individual skins are shown in Fig. 3a-c, whereas data for all skin, in which the 18 
17 
 
depth was normalized by the thickness of the SC, are shown in Fig. 3d.  The steady 1 
state LID concentration in the SC decreased linearly as permeation deepened.  The 2 
calculated LID concentration-depth profile was almost the same as the observed profile. 3 
 4 
Fig. 3 5 
 6 
Fig. 4 shows the relationship between the observed and calculated values for 7 
steady state LID concentrations at various depths in the VED following the application 8 
of pH 7.4 donor solution.  Permeation parameters, which were obtained from the 9 
corresponding permeation experiments through full-thickness and stripped skins (Fig. 2), 10 
were used in the calculation using equation (3).  The thickness of the VED was 11 
different among skins, which was similar to that observed in the SC; therefore, the raw 12 
data for each skin are shown in Fig. 4a-e and data normalized by depth VED thickness 13 
are shown in Fig. 4f.  The concentration of LID decreased linearly as the site became 14 
deeper. The calculation performed based on permeation data provided an almost 15 
identical concentration-depth profile to the observed profile.  16 
 17 
Fig. 4 18 
18 
 
 1 
Fig. 5 shows the steady state LID concentration-depth profile for full-thickness 2 
skin, which was constructed by combining the data in Fig. 3d with those in Fig. 4f.  3 
The concentration gradient was significantly higher in the SC than in the VED.  The 4 
profile was a typical one of the two-layered skin model shown in Fig. 1.   5 
 6 
Fig. 5 7 
 8 
4. Discussion 9 
 10 
The efficacies and toxicities of topically applied drugs and cosmetics are 11 
determined by their concentrations in the skin, and sites of action are distributed over a 12 
wide area of the skin. Melanin, which causes pigmentation, is produced by 13 
melanosomes in the basal layer of the viable epidermis (Seiji et al., 1961). Effective 14 
concentrations of arbutin (Maeda and Fukuda, 1996) and kojic acid (Mishima et al., 15 
1988) are required in the viable epidermis in order to inhibit melanin production.  16 
Vitamin A has been shown to improve blood flow (Kligman, 1989) and, thus, its 17 
efficacy is affected by its concentration in the dermis.  Therefore, knowing the 18 
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concentrations of active compounds in the skin, especially the target tissue, is of 1 
importance. 2 
LID is mainly used as an antiarrhythmic or topical anesthetic, and transdermal 3 
tape has also been developed for the treatment of neuralgia and numbness in the limbs.  4 
Since its molecular weight is 234.34 and logarithm of the octanol/PBS partition 5 
coefficient is 0.23 (32°C), the skin permeability of LID is relatively high (Bos and 6 
Meinardi, 2000; Leo and Hansch, 1971).  Based on these findings, LID was used as a 7 
model penetrant in the present study.   8 
LID contains an amino group (pKa 7.8, JPEC, 2010), and the fraction of 9 
ionization is known to vary depending on the pH of the formulation.  In the present 10 
study, the unionized fractions accounted for 0.16, 28.5 and 99.4% in the pH 5.0, 7.4, 11 
and 10 donor solutions respectively.  The cumulative amount of LID that permeated 12 
through full-thickness skin increased with an increase in the fraction of the unionized 13 
form of LID in the donor solution (Fig. 2).  When the compound exists as unionized 14 
and ionized compound forms, the total permeability coefficient (P) can be described as 15 
follows (Hayashi et al., 1992) 16 
iu
iiuu
CC
PCPC
P
+
+
=
                                               
(4) 17 
where Cu and Ci are the concentrations in the donor solution, and Pu and Pi are the 18 
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permeability coefficients for the unionized and ionized forms.  The permeation rate of 1 
the unionized and ionized forms of LID from the pH 7.4 donor solution through 2 
full-thickness skin (CuPu and CiPi) was calculated using equation (4).  The resulting 3 
values of CuPu and CiPi were 7.1×10-4 and 3.4×10-5 cm/s, which revealed the 4 
significantly lower skin permeability of the ionized form than of the unionized one.  5 
The SC, which is the main permeation barrier of full-thickness skin, is considered as a 6 
lipophilic membrane; therefore, permeation through the SC may be difficult for ionized 7 
LID (Swarbrick et al., 1992; Hatanaka et al., 1995; Hatanaka et al., 1996).  The pH 8 
values of the VED before and after the permeation experiments were approximately 7.4, 9 
regardless of the applied donor solutions (Table 2), and both the unionized and ionized 10 
forms of LID permeated through these layers.  On the other hand, the difference in 11 
LID permeated from donor solutions having various pH values was lower for stripped 12 
skin than for full-thickness skin (Fig. 2); therefore permeation of ionized LID cannot be 13 
ignored for stripped skin. 14 
The LID concentration-depth profile for full-thickness skin (Fig. 5) was typical 15 
for the two-layered skin permeation model shown in Fig. 1.  Because the concentration 16 
ratio of the Line segment ab against bc at the surface between the SC and VED 17 
represented the permeation resistance ratio of the SC against the VED, the ratio of the 18 
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concentration at x = Lsc against that at x = 0 in the SC should signify the permeability 1 
coefficient ratio of stripped skin against full-thickness skin (Sugibayashi et al., 2010).  2 
The concentration ratio of the surface against the dermis side of the SC was 0.061 (Fig. 3 
3), while the permeability coefficient ratio was 0.056 (Fig. 2, Table 1).  Based on the 4 
two-layered model, skin permeation parameters were determined from the 5 
corresponding permeation data through full-thickness and stripped skins, and LID 6 
concentrations at various skin depths were subsequently calculated using these 7 
parameters.  LID concentrations as well as the mean skin concentration could be 8 
predicted at each depth (Figs. 3-5) (Sugibayashi et al., 2010).   9 
Although skin permeation parameters were obtained from animal experiments 10 
in the present study, these parameters can be predicted using the physicochemical 11 
properties of compounds (Hatanaka et al., 1990; Potts and Guy, 1992; Geinoz et al., 12 
2004).  Skin concentration-depth profiles may also be predicted without animal 13 
experiments, such that animal species differences can be disregarded (Bartek et al., 14 
1972; Bronaugh et al., 1982; Sato et al., 1989).   15 
In the present study, LID, which is relatively lipophilic, was used as the model 16 
penetrant.  Since the skin is a lipophilic two-layered membrane, the prediction of skin 17 
concentration-depth profiles may be insufficient for hydrophilic compounds. (Feldmann 18 
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and Maibach, 1967; Ogiso et al., 2002; Oshizaka et al., 2012).  The contribution of 1 
appendages or the hydrophilic pathway (Hatanaka et al, 1990) must be considered for 2 
more accurate predictions.  Furthermore, because predictions were only made under 3 
steady state permeation in this study, comprehensive dermatokinetics including 4 
non-steady state permeation are required.   5 
In conclusion, penetrant concentration-skin depth profiles can be predicted 6 
easily by analyzing skin permeation data according to Fick’s diffusion law.  This 7 
method will be useful for promoting the efficient preparation of topically applied drugs 8 
and cosmetics. 9 
 10 
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Table 1 
Skin permeation parameters of LID  
 Ptot (cm/s) Pved (cm/s) Ksc Kved 
pH 5.0 4.7×10-8 1.5×10-5 0.098 2.6 
pH 7.4 2.4×10-6 4.3×10-5 7.2 7.3 
pH 10 2.5×10-6 6.0×10-5 7.9 7.5 
31 
 
 1 
aEach value represents the mean ± S.E. of 3 experiments.  2 
3 
Table 2 
pH values on the surface and dermis sides of skin before and after the permeation experimentsa 
 
Full-thickness skin Stripped skin 
Before 
After  After 
pH 5.0 pH 7.4 pH 10 pH 5.0 pH 7.4 pH 10 
Stratum 
corneum 
6.2 ± 0.033 6.0 ± 0.058 6.2 ± 0.088 8.8 ± 0.058 - - - 
Viable 
epidermis 
7.4 ± 0.033 7.4 ± 0.088 7.4 ± 0.0 7.4 ± 0.058 7.1 ± 0.15 7.3 ± 0.058 9.8 ± 0.033 
Dermis 7.5 ± 0.12 7.3 ± 0.033 7.3 ± 0.033 7.9 ± 0.033 7.4 ± 0.033 7.3 ± 0.033 8.9 ± 0.058 
32 
 
Fig. 1.  Schematic diagram of the concentration-depth profile in the two-layered 1 
diffusion model.  Cv is the penetrant concentration in vehicle, Ksc is the partition 2 
coefficient of the penetrant from vehicle to the SC, Lsc and Lved are the thicknesses of 3 
the SC and VED, respectively. 4 
Fig. 2.  Cumulative amounts of LID that permeated through full-thickness (a) and 5 
stripped skins (b) from donor solutions at several pHs.  Each value represents the mean 6 
± S.E. of 3 experiments.   7 
Fig. 3.  Steady state LID concentrations at various depths in the SC (a) and those 8 
normalized by the SC thickness (b) after the application of pH 7.4 donor solution.  9 
Each symbol represents individual skin.  The dashed line is the concentration 10 
calculated by equation (2) using permeation parameters. 11 
Fig. 4.  Steady state LID concentrations at various depths in the VED (a) and those 12 
normalized by the VED thickness (b) after the application of pH 7.4 donor solution.  13 
Each symbol represents individual skin.  The dashed line is the concentration 14 
calculated by equation (3) using permeation parameters. 15 
Fig. 5.  Steady state LID concentration-depth profile for full-thickness skin after the 16 
application of pH 7.4 donor solution.  This profile was constructed by combining data 17 
from Fig. 3d and Fig. 4f. 18 
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